Navigation Links
OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
Date:4/15/2008

AMSTERDAM, April 15 /PRNewswire/ -- SynCo Bio Partners B.V., a leading GMP biopharmaceutical manufacturer, has signed a Master Services Agreement with OncoMed Pharmaceuticals, a company developing novel therapeutics that target cancer stem cells. Under the agreement, SynCo will fill and finish batches of OncoMed's lead product, antibody OMP-21M18, for use in Phase I clinical trials.

Announcing the agreement, Pierre Warffemius, CEO, said, "We are delighted that a company at the forefront of cancer therapies has recognised our expertise in biopharmaceutical processing by choosing us to fill their lead antibody for early clinical trails."

Paul J. Hastings, President and CEO of OncoMed, "We selected SynCo Bio Partners because we needed a GMP-accredited contract manufacturing organisation that had a proven track record in filling biologics. With SynCo's expertise in all aspects of biopharmaceutical manufacture, they were an ideal partner for us at this crucial stage in our development."

OncoMed recently announced that it had signed a worldwide strategic alliance with GSK to develop cancer stem cell antibody therapeutics. One of the key projects in this alliance will be the development of OncoMed's lead antibody product candidate, OMP-21M18, a monoclonal antibody, which is scheduled to enter the clinic in 2008.

SynCo will fill and finish antibody OMP-21M18 at its Amsterdam-based facility. This facility is able to fill a wide range of biopharmaceuticals into vials, including protein, polysaccharide, and live-microbial-based products using the latest filling and finishing equipment.

Issued on behalf of SynCo Bio Partners by De Facto Communications

About SynCo Bio Partners B.V.

SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with in-depth clinical and commercial production experience with mammalian and microbial systems. This experience has been acquired by developing new production proces
'/>"/>

SOURCE SynCo Bio Partners B.V.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , CHICAGO, Nov. 30 Dr. Jocely...nd Intervention at George Washington University Me... occult lesions identified with Breast-Specific Ga...i-modality imaging for needle biopsy as well, as f...meeting of the Radiological Society of North Ameri...
(Date:11/30/2009)... , BOZEN, Italy, November 30 /PRNewswi...o unveil TPNstation,s development plans and produc...pt: "Totally Automated Parenteral,Nutrition", a ne...ion to be,showcased at Las Vegas, ASHP (Booth # 11... from our customers to the,TPNstation,s blueprints...
(Date:11/30/2009)... , WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswi...nnual Meeting of the Radiological Society of Nor...s Inc. announced the enrollment of the first patie... evaluate the efficacy and safety of florbetaben (...Amyloid plaques in the brain, which are a patholog...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3AAAS exhibit featuring photographs of climate change opens Nov 18 10697 1AAAS exhibit featuring photographs of climate change opens Nov 18 10697 2AAAS exhibit featuring photographs of climate change opens Nov 18 10697 3Early life on Earth may have developed more quickly than thought 10695 1Early life on Earth may have developed more quickly than thought 10695 2Dyslexia May Make It Tough to Tune Out School Noise 61160 1Dyslexia May Make It Tough to Tune Out School Noise 61160 2
...neRx Ltd.,(TASE:BLRX), Israel,s leading drug devel...rom trials of BL-1040 demonstrating that,BL-1040 i...cardium,after a myocardial infarction (MI), thereb...heart failure in a pig model. Professor,Jonathan L...Institute at Sheba Medical Center in Israel, prese...
...merican College of,Cardiology,s Scientific Session...FirstCall/ -- CV,Therapeutics, Inc. announced toda...IN TIMI-36 study of ranolazine shows there was no,...on ranolazine.,The study did not meet the primary ...y,s special protocol assessment,agreement with the...
Other Medicine Technology:BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3
(Date:11/30/2009)... ebb, CDC notes a rise in child deaths linked to f...) -- U.S. health officials said Monday that H1N1 ...onally, even as the number of American children dy...atest report, released Monday by the U.S. Centers ...at "visits to doctors for influenza-like illness n...
(Date:11/30/2009)... Nov. 30 SEIU Local 21L...corporation Sodexo will hold a rally Tuesday, Dec....ance headquarters, 3800 Desire Parkway, New Orlean...itrary disciplinary policies that target employees... member. Sodexo employees who clean schools in the...
(Date:11/30/2009)...Calif., Nov. 30 Jedi Mi...) is pleased to announce the Company,s first thoug...urchase. The game, "Think-Tac-Toe" is the first of...with the power of their mind and is geared towards...at a price of $49 and can be purchased directly th...
(Date:11/30/2009)... , Study Uses Tent To Simulate High Altitude...Newswire-USNewswire/ -- Distance runners who live ... to improve their performance during races in area...nts, who suffer from fatigue, improve their exerci...itude simulator? ,, That is the question being ...
(Date:11/30/2009)..., Switzerland, Nov. 30 T...ced that its 2010 annual general meeting of shareh...t 3:00 p.m. Central European time at the Park Hyat... Switzerland. Registered shareholders as of Januar...ote at the annual general meeting. Additionally, ...
Breaking Medicine News(10 mins):Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4
...AGO Women who live in urban areas have denser bre...ncer, according to a study presented today at the ...h America (RSNA)., Women living in cities need to ...t The Princess Grace Hospital in London, U.K. Curr...
...Centenary Institute, one of Australias leading med...oscope unlike any other in Australia today.,Repres...microscopy, the unique imaging,features of the mul...d molecular,level., The Centenary Institute is equ...
...althcare to expand PACS portfolio through Visage C...de advanced visualization solut...v. 26 Visage Imaging, a,wholly owned subsidiary o...linical workflow and diagnostic imaging solutions,...
...GO, Nov. 26 Volcano Corporation,(Nasdaq: VOLC ),...,functional measurement (FM) products designed to ...d structural heart disease, said today that it wil...t and chief executive,officer, will be begin at 3 ...
...udy shows that short, intense bouts help maintain ...dy aimed at understanding the health of female ast...ssions can help women on bed rest recuperate more ... muscle loss in female astronauts on long-duration...
...ted to Aggressive Product Innovation and Effective..., HONG KONG, Nov. 26 /Xinhua-PRNewswire-FirstCall... Vitasoy or "the Group") (HKEx: 0345),a Hong Kong-...grew by 14.2%, to HK$1,514 million. The Group reco...
Other Medicine News:Health News:City-dwelling women at greater risk for breast cancer 2Health News:World class technology and talent battle cancer at the Centenary Institute 2Health News:Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites 2Health News:Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites 3Health News:Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites 4Health News:Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites 5Health News:Volcano Corporation Presentation at Piper Jaffray Conference to be Webcast 2Health News:Exercise May Help Female Astronauts Stay Strong 2Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 2Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 3Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 4Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 5
Dual-bay Dyad thermal cycler chassis
RoboCycler 40 Temperature Cycler
...Cycler is the first instrument engineered to match...t's rapid temperature cycling system is based on h...crocapillary tubes or thin walled micorcentrifuge ... of high velocity air results in nearly instantane...
Primus 25 Legal PCR System
Medicine Products: